Michael B Streiff

Professor

1990 …2019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Michael B Streiff is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 3 Similar Profiles
Venous Thromboembolism Medicine & Life Sciences
Anticoagulants Medicine & Life Sciences
Venous Thrombosis Medicine & Life Sciences
Vena Cava Filters Medicine & Life Sciences
Pulmonary Embolism Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Thrombosis Medicine & Life Sciences
Heparin Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1990 2019

Anti-Xa activity by weight in critically ill patients receiving unfractionated heparin for venous thromboembolism prophylaxis

Aggarwal, M. V., Jarrell, A. S., Gilmore, V. T., Aboagye, J. K., Haut, E., Hobson, D. B., Lau, B., Kickler, T. S., Kraus, P. S., Shaffer, D. L., Shermock, K. M., Streiff, M. B., Zheng, G. & Kruer, R. M., Aug 1 2019, In : Journal of Critical Care. 52, p. 180-185 6 p.

Research output: Contribution to journalArticle

Venous Thromboembolism
Critical Illness
Heparin
Weights and Measures
Prospective Studies

Etiology and management of upper-extremity catheter-related thrombosis in cancer patients

Rajasekhar, A. & Streiff, M. B., Jan 1 2019, Cancer Treatment and Research. Springer International Publishing, p. 117-137 21 p. (Cancer Treatment and Research; vol. 179).

Research output: Chapter in Book/Report/Conference proceedingChapter

Upper Extremity
Thrombosis
Catheters
Neoplasms
Equipment and Supplies

Evaluation of Global Hemostatic Assays in Response to Factor VIII Inhibitors

Chen, P., Jani, J., Streiff, M. B., Zheng, G. & Kickler, T. S., Mar 15 2019, In : Clinical and Applied Thrombosis/Hemostasis. 25

Research output: Contribution to journalArticle

Factor VIII
Hemostatics
Thrombin
Thrombelastography
Reference Values

Fibrinogen consumption and use of heparin are risk factors for delayed bleeding during acute promyelocytic leukemia induction

Hambley, B. C., Norsworthy, K. J., Jasem, J., Zimmerman, J. W., Shenderov, E., Webster, J., Showel, M., Gondek, L., Dalton, W., Prince, G., Gladstone, D., Streiff, M. B., Pratz, K., Gojo, I., Ghiaur, G., Levis, M. J., Smith, B. D. & Dezern, A., Aug 1 2019, In : Leukemia Research. 83, 106174.

Research output: Contribution to journalLetter

Acute Promyelocytic Leukemia
Fibrinogen
Heparin
Hemorrhage

Healthcare resource utilization and costs associated with venous thromboembolism in cancer patients treated with anticoagulants

Streiff, M. B., Milentijevic, D., McCrae, K. R., Laliberté, F., Lejeune, D., Lefebvre, P., Schein, J. & Khorana, A. A., Jan 1 2019, In : Journal of Medical Economics.

Research output: Contribution to journalArticle

Open Access
Venous Thromboembolism
Anticoagulants
Low Molecular Weight Heparin
Delivery of Health Care
Costs and Cost Analysis